Resverlogix Corp. (RVX.TO)

CAD 0.05

(12.5%)

Revenue Summary of Resverlogix Corp.

  • Resverlogix Corp.'s latest annual revenue in 2022 was - USD , down 0.0% from previous year.
  • Resverlogix Corp.'s latest quarterly revenue in 2023 Q1 was - USD , down 0.0% from previous quarter.
  • Resverlogix Corp. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • Resverlogix Corp. reported a annual revenue of - USD in annual revenue 2020, down 0.0% from previous year.
  • Resverlogix Corp. reported a quarterly revenue of - USD for 2023 Q2, down 0.0% from previous quarter.
  • Resverlogix Corp. reported a quarterly revenue of - USD for 2023 Q3, down 0.0% from previous quarter.

Annual Revenue Chart of Resverlogix Corp. (2022 - 2001)

Historical Annual Revenue of Resverlogix Corp. (2022 - 2001)

Year Revenue Revenue Growth
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD -100.0%
2010 82.87 Thousand USD 2856.12%
2009 2803.53 USD -97.97%
2008 138.16 Thousand USD 0.0%
2007 - USD -100.0%
2006 289.95 Thousand USD 19.01%
2005 243.63 Thousand USD 39.18%
2004 175.05 Thousand USD 895.15%
2003 17.59 Thousand USD 0.0%
2002 - USD -100.0%
2001 5901.79 USD 0.0%

Peer Revenue Comparison of Resverlogix Corp.

Name Revenue Revenue Difference
Appili Therapeutics Inc. 827.4 Thousand CAD 100.0%
Eupraxia Pharmaceuticals Inc. - CAD NaN%
Helix BioPharma Corp. - CAD NaN%
Microbix Biosystems Inc. 16.51 Million CAD 100.0%
Medicenna Therapeutics Corp. - CAD NaN%
Satellos Bioscience Inc. - CAD NaN%
Oncolytics Biotech Inc. - CAD NaN%
Sernova Corp. - CAD NaN%